1. Home
  2. JWEL vs NCNA Comparison

JWEL vs NCNA Comparison

Compare JWEL & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jowell Global Ltd.

JWEL

Jowell Global Ltd.

N/A

Current Price

$2.32

Market Cap

5.1M

ML Signal

N/A

Logo NuCana plc

NCNA

NuCana plc

HOLD

Current Price

$3.29

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JWEL
NCNA
Founded
2012
1997
Country
China
United Kingdom
Employees
N/A
22
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
13.8M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
JWEL
NCNA
Price
$2.32
$3.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.8K
51.9K
Earning Date
05-12-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$132,981,531.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$2.78
52 Week High
$3.26
$330.00

Technical Indicators

Market Signals
Indicator
JWEL
NCNA
Relative Strength Index (RSI) 51.17 41.29
Support Level $2.24 $3.16
Resistance Level $2.41 $4.55
Average True Range (ATR) 0.11 0.24
MACD -0.04 -0.05
Stochastic Oscillator 63.68 17.99

Price Performance

Historical Comparison
JWEL
NCNA

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Share on Social Networks: